Show Summary Details
Reference may be made to material that has no named author or is prepared by a committee or other group. The following forms are used: 1. Ferguson JJ, Califf RM, Antman EM, et al; SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA.2004;292(1):45-54. 2. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572. 3. Centers for Disease Control and Prevention (CDC). Prevalence of receiving multiple preventive-care services among adults with
Other Material Without Named Author(s) or With Named Authors and a Group Name
Other Material Without Named Author(s) or With Named Authors and a Group Name
Access to the complete content on AMA Manual of Style requires a subscription or purchase. Public users are able to search the site without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
